Source - SMW
Amryt Pharma has signed a distributorship agreement with Faisal Musaed El Seif Saudi Pharmaceutical Co, for Amryt's products in  Saudi Arabia.

Amryt said this exclusive agreement covered Lojuxta (lomitapide) and AP101, the company's clinical stage product, currently in phase 3 trials. 

Amryt said El Seif, an affiliate of El Seif Development Company, was a leading distributor of medical devices and pharmaceuticals in Saudi Arabia, and has a strong presence in the rare and orphan diseases drug sector.

At 9:45am: (LON:AMYT) Amryt Pharma share price was +0.25p at 19.38p